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Beef carcass sponge samples collected from July to August 1999 at four large processing plants in the United
States were surveyed for the presence of non-O157 Shiga toxin-producing Escherichia coli (STEC). Twenty-eight
(93%) of 30 single-source lots surveyed included at least one sample containing non-O157 STEC. Of 334
carcasses sampled prior to evisceration, 180 (54%) were found to harbor non-O157 STEC. Non-O157 STEC
isolates were also recovered from 27 (8%) of 326 carcasses sampled after the application of antimicrobial
interventions. Altogether, 361 non-O157 STEC isolates, comprising 41 different O serogroups, were recovered.
O serogroups that previously have been associated with human disease accounted for 178 (49%) of 361 isolates.
Although 40 isolates (11%) carried a combination of virulence factor genes (enterohemorrhagic E. coli hlyA, eae,
and at least one stx gene) frequently associated with STEC strains causing severe human disease, only 12 of
these isolates also belonged to an O serogroup previously associated with human disease. Combining previ-
ously reported data on O157-positive samples (R. O. Elder, J. E. Keen, G. R. Siragusa, G. A. Barkocy-
Gallagher, M. Koohmaraie, and W. W. Laegreid, Proc. Natl. Acad. Sci. USA 97:2999–3003, 2000) with these
data regarding non-O157-positive samples indicated total STEC prevalences of 72 and 10% in preevisceration
and postprocessing beef carcass samples, respectively, showing that the interventions used by the beef-
processing industry effected a sevenfold reduction in carcass contamination by STEC.
Shiga toxin-producing Escherichia coli (STEC) has been im-
plicated as the causative agent in several human diseases (22,
27). These diseases range from mild diarrhea to very severe
and life-threatening conditions, such as hemolytic-uremic syn-
drome (HUS). Enterohemorrhagic E. coli (EHEC) refers to
the subset of STEC strains found to cause human disease. The
STEC strain most frequently associated with clinical disease in
the United States is serotype O157:H7 (20, 22). However,
several other serotypes (O26, O103, O111, O113, and O121)
are commonly associated with severe disease outbreaks and, in
some countries, are isolated from clinical cases more often
than O157 (1, 22). It has been estimated that E. coli O157:H7
strains cause two-thirds of the human EHEC infections in the
United States, with the remaining cases attributed to the non-
O157 STEC population (20). This estimation may be biased
toward O157 because several clinical laboratories only screen
for E. coli O157:H7, leaving non-O157 EHEC-associated dis-
eases underreported (20).
Cattle are considered the primary reservoir of both O157
and non-O157 STEC bacteria (4). Cattle frequently carry
STEC without suffering from any pathological symptoms (6,
42). Several human infections have been linked to STEC
present in undercooked ground beef (22, 36). During process-
ing, fecal contamination of the carcass or transfer of bacteria
found on the animal hide to the carcass can facilitate trans-
mission of STEC into the food supply (2, 3, 13).
The complete list of bacterial virulence determinants neces-
sary for STEC to cause EHEC-related disease is not known.
However, the Shiga toxin is a key factor in pathogenesis (1, 27).
Two classes of Shiga toxin have been identified. Shiga toxin 1
(Stx1) is 98% homologous to the Stx produced by Shigella
dysenteriae type 1 (22, 27). Stx2 is approximately 60% homol-
ogous to Stx1 and is antigenically distinct (22, 27). Recent
studies have indicated that strains possessing stx2 are poten-
tially more virulent than strains carrying stx1 or even strains
carrying both stx1 and stx2 (11, 22, 23, 32, 39). Other virulence
factors, such as intimin (eae) and EHEC hemolysin (hlyA), are
thought to enhance pathogenicity but are not required for
strains to cause severe disease, including HUS (1, 8, 22).
The objective of this study was to determine the prevalence
and virulence profiles of non-O157 STEC on beef carcasses at
commercial processing plants in the United States during the
summer months. Such data will contribute to the establishment
of baseline prevalence levels of non-O157 STEC. The samples
used for this study were originally collected by Elder et al. for
a survey of O157:H7 prevalence (13). Extrapolation of the data
from both studies provides an indication of the total STEC
prevalence in U.S. beef-processing plants.
MATERIALS AND METHODS
Carcass samples. Sponge samples were collected by Elder et al. from beef
cattle carcasses during processing (13). Briefly, individual carcasses were fol-
lowed through processing and sampled at various points. Speci-Sponges (Nasco,
Fort Atkinson, Wis.) moistened with Butterfield’s phosphate diluent and 0.1%
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Tween 20 were used to sample carcasses just prior to evisceration (preeviscera-
tion) and after all antimicrobial interventions when the carcasses were in the
cooler (postprocessing). Lots of 35 to 85 animals were sampled. A lot is defined
as cattle from a single source and maintained as a group throughout processing.
Twenty percent of the carcasses in each lot were sampled. Antimicrobial inter-
ventions varied between plants and included steam vacuuming, hot water wash-
ing, organic acid washing, and steam pasteurization.
Bacterial culture. Beef carcass sponge samples were enriched by incubation
with 90 ml of Brilliant Green Bile 2% (40 g/liter) for 10 h at 37°C (13). Following
enrichment, 1 ml of culture was added to 250 l of 50% glycerol and stored at
70°C. The enrichments were stored frozen for approximately 2 years prior to
initiation of this study.
PCR screening of samples. Samples that were not previously determined to be
positive for E. coli O157:H7 (13) were screened for the presence of stx1 and stx2
by PCR. The procedure used is a modification of that described by Paton and
Paton (24). Briefly, a 50-l sample was removed from the frozen enrichment and
centrifuged for 1 min at 12,000  g in a microcentrifuge and the supernatant was
discarded. The pellet was resuspended in 200 l of sterile water and centrifuged
again, and the supernatant was discarded. The pellet was resuspended in 50 l of
sterile water and boiled for 15 min. The lysate was spun briefly, and 2 l was used
as template DNA in a 30-l PCR.
Colony hybridization. All samples previously determined to be E. coli
O157:H7 positive (13), as well as samples determined by PCR to contain either
stx1 or stx2, were assayed by colony hybridization for STEC detection. Samples
from the frozen enrichments were serially diluted in buffered peptone water and
plated onto tryptic soy agar in 182-mm-diameter petri dishes to achieve a colony
count of 2,000 CFU per plate. The plates were incubated for 11 h at 37°C and
then transferred to 4°C for 30 min. The colonies were blotted to Hybond N
membranes (Amersham Pharmacia Biotech, Piscataway, N.J.), and hybridization
(60°C) and detection were carried out by using the ECL Random Prime Labeling
and Detection kit (Amersham) and following the manufacturer’s instructions.
The membranes were hybridized with 90 ng of both stx1 and stx2 probes in 50 ml
of hybridization buffer. The DNA probes for random prime labeling were de-
rived via PCR from E. coli O157 strain ATCC 43895 by using the following
primers: stx1-F (bp 77 to 102 of Sakai-VT1; 5-CCTTAGACTTCTCGACTGC
AAAGACG-3), stx1-R (bp 894 to 913 of Sakai-VT1; 5-CCAGAGTGGATGA
ATCCCAC-3), stx2-LP43 (bp 57 to 78 of EDL933; 5-ATCCTATTCCCGGG
AGTTTACG-3), and stx2-LP44 (bp 622 to 643 of EDL933; 5-GCGTCATCG
TATACACAGGAGC-3) (9).
Isolation and characterization of STEC. The developed films from the colony
blots were aligned with the original plates, and up to three suspect colonies per
sample were patched in a grid on tryptic soy agar. The patch plates were again
colony blotted to identify those colonies that were correctly picked. The positive
patches were then streaked for isolation on sorbitol MacConkey agar (SMAC).
From each SMAC streak plate, two colonies were picked and screened for the
EHEC genes stx1, stx2, eae, and EHEC hlyA by multiplex PCR (24). Any colony
possessing stx1 or stx2 was assayed for expression of the O157 antigen by latex
agglutination with the Dryspot E. coli O157 Latex Test (Oxoid, Basingstoke,
England). Colonies giving a positive agglutination reaction were discarded. All
non-O157, stx-containing isolates were confirmed to be E. coli by biochemical
identification with the Sensititre Gram-Negative Autoidentification (AP80) sys-
tem (Accumed International, Westlake, Ohio) or API 20E strips (bioMérieux,
Hazelwood, Mo.).
ETEC and EPEC PCR. Selected strains were screened by PCR for virulence
attributes commonly associated with enterotoxigenic E. coli (ETEC; heat-stable
and heat-labile toxins) and enteropathogenic E. coli (EPEC; bundle-forming
pilus and EAF plasmid) by using methods described previously (15, 35, 43).
Serotyping. All STEC isolates were serotyped in accordance with their O and
H antigens by the E. coli Reference Center (Pennsylvania State University,
University Park).
Statistics. Confidence intervals were calculated by using the method presented
by Wardrup (40).
RESULTS
Prevalence of non-O157 STEC. Any sample that produced at
least one non-O157 E. coli isolate harboring a Shiga toxin gene
was considered positive for non-O157 STEC. One hundred
eighty (53.9%) of 334 preevisceration samples and 27 (8.3%)
of 326 postprocessing samples were positive for non-O157
STEC (Table 1). Multiple isolates were recovered from 90 of
the 180 positive preevisceration samples and 17 of the 27
positive postprocessing samples. A total of 361 non-O157
STEC isolates were recovered.
At preevisceration, 58.3% of samples that were previously
determined to carry E. coli O157:H7 (13) also were positive for
non-O157 STEC (Table 1). Of those samples that were nega-
tive for O157 (13), 50.5% produced a non-O157 STEC isolate.
However, PCR results indicated that 76.8% of these samples
contained either one or both of the Shiga toxin genes (data not
shown). Twenty-seven (8.4%) of 320 O157:H7-negative post-
processing samples were positive for non-O157 STEC (Table
1). However, PCR results indicated that 43 (13.4%) of the
samples contained either one or both of the Shiga toxin genes
(data not shown). There were no E. coli O157:H7-positive
postprocessing samples (13) that also carried a non-O157
STEC isolate (Table 1). Seven of the non-O157 STEC-positive
postprocessing samples were from carcasses that were not
found to be positive preevisceration.
Twenty-eight (93.3%) of 30 lots produced at least one pree-
visceration sample that was positive for non-O157 STEC (Ta-
ble 2). The prevalence of positive preevisceration samples
within a lot ranged from 0 to 100%. Eleven lots that had at
least one positive preevisceration sample did not have a posi-
tive postprocessing sample. Seventeen (56.7%) of 30 lots pro-
duced at least one postprocessing sample that was positive for
non-O157 STEC (Table 2). All 17 positive postprocessing lots
were also positive preevisceration. The prevalence of positive
samples within postprocessing lots ranged from 0 to 33.3%.
Total STEC prevalence. Elder et al. originally collected the
carcass samples used in this study for a survey of E. coli
O157:H7 prevalence (13). The E. coli O157:H7 prevalence in
these samples was determined to be 43.4 and 1.9% for pree-
visceration and postprocessing, respectively (13). By merging
the data from the two studies, the total STEC prevalence on
TABLE 1. Summary of STEC prevalencea
Sample
category
Total no. of
samples
Total no. (%) non-O157
STEC positive 95% CI
b
No. (%) of samples:
Total no. (%)
STEC positivedO157:H7 positive,c non-O157
STEC positive
O157:H7 negative,c non-O157
STEC positive
Preevisceration 334 180 (53.9) 48.5–59.2 144, 84 (58.3) 190, 96 (50.5) 240 (71.9)
Postprocessing 326 27 (8.3) 5.3–11.3 6, 0 320, 27 (8.4) 33 (10.1)
a Values represent numbers of carcass samples carrying at least one non-O157 STEC isolate.
b 95% CI, 95% confidence interval.
c See Elder et al. (13).
d STEC-positive samples (O157 and non-O157) from this work and that of Elder et al. (13).
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carcasses was determined to be 71.9% preevisceration and
10.1% postprocessing (Table 1).
Characterization of isolates. All non-O157 isolates were
confirmed as E. coli by biochemical assay, and all isolates were
confirmed by PCR to carry the stx1 and/or stx2 genes. Eight
percent of the isolates (29 of 361) did not ferment sorbitol on
the basis of growth on SMAC. The distribution of virulence
factors among the non-O157 STEC isolates is summarized in
Table 3. With regard to Shiga toxin genes, PCR results indi-
cated that 170 (47.1%) of the isolates carried stx1, 132 (36.6%)
had stx2, and 59 (16.3%) possessed both stx1 and stx2. The eae
gene was present in 43 isolates (11.9%), and EHEC hlyA was
found in 98 (27.1%) of the non-O157 STEC isolates. Strains
carrying only stx1, without any other virulence factors for which
we tested, accounted for the dominant share of isolates, at
42.1% (152 of 361). Forty isolates (11.1%) possessed the com-
bination of virulence factors (eae, EHEC hlyA, and at least one
Shiga toxin gene) that has been associated with severe disease
in humans (1, 12, 14). Only four of these isolates were recov-
ered from postprocessing samples. Of the 90 preevisceration
samples that yielded multiple isolates, 25 had isolates of dif-
ferent virulence genotypes. Only one postprocessing sample
yielded isolates of different virulence genotypes.
Serotype distribution. Seventy-five percent of the isolates
could be serogrouped in accordance with their O antigen, but
only 21% could be typed by their H antigen (data not shown).
Forty-one O serogroups were identified (Table 4). No isolates
of serogroup O26 or O111 were recovered. Eight serogroups
(O2, O8, O88, O113, O121, O132, O142, and O171) accounted
for 49% of the STEC isolates. O142, a serogroup rarely asso-
ciated with STEC (34), was the most prevalent serogroup
among both preevisceration and postprocessing isolates. Two
isolates were recovered that were of a serogroup (OX25) not
previously associated with STEC. O serogroups that have been
associated with human disease accounted for 178 (49%) of the
361 isolates recovered.
Sixty-two preevisceration samples yielded multiple non-
O157 isolates with typeable O antigens. Within 16 of these
samples, isolates of different serogroups were identified. In two
such samples, all three isolates were of different serogroups.
TABLE 2. Prevalence of non-O157 STEC by lot
Plant Sampling Lot na
No. of samples
positive/totalb (%)
Preevisceration Postprocessing
A 1 1 84 6/18 (33.3) 0/18 (0)
2 35 5/8 (62.5) 1/7 (14.3)
3 68 1/15 (6.7) 0/16 (0)
2 1 80 14/18 (77.8) 2/18 (11.1)
2 41 8/10 (80.0) 2/9 (22.2)
3 62 11/14 (78.6) 2/13 (15.4)
4 44 8/13 (61.5) 1/13 (7.6)
B 1 1 46 0/11 (0) 0/9 (0)
2 37 0/9 (0) 0/9 (0)
3 39 6/9 (66.7) 1/9 (11.1)
4 48 3/12 (25.0) 2/12 (16.7)
2 1 36 2/9 (22.2) 0/9 (0)
2 36 6/8 (75.0) 0/9 (0)
3 36 8/9 (88.9) 0/7 (0)
4 40 10/10 (100) 1/10 (10.0)
C 1 1 41 6/10 (60.0) 0/10 (0)
2 76 10/17 (58.8) 1/17 (5.9)
3 42 7/10 (70.0) 1/10 (10.0)
4 38 10/10 (100) 2/9 (22.2)
2 1 38 10/10 (100) 0/10 (0)
2 44 5/9 (55.6) 1/10 (10.0)
3 40 9/11 (81.8) 2/11 (18.2)
4 46 9/12 (75.0) 4/12 (33.3)
D 1 1 37 4/7 (57.1) 1/8 (12.5)
2 39 4/7 (57.1) 1/5 (20.0)
3 38 2/8 (25.0) 0/8 (0)
4 42 1/8 (12.5) 2/8 (25.0)
2 1 65 4/14 (28.6) 0/13 (0)
2 42 2/11 (18.2) 0/11 (0)
3 58 9/17 (52.9) 0/16 (0)
Cumulative totals 180/334 (53.9) 27/326 (8.3)
a Number of animals in lot.
b Values represent the number of positive samples over the total number of
carcasses sampled per lot.
TABLE 3. Virulence factors of non-O157 STEC isolates
STEC virulence
factor(s)
No. of isolatesa
O serogroupsb
Total Preevis Post
stx1 152 135 17 2, 3, 8, 45, 68, 74, 81, 119, 121, 128, 132, 142, 172, NT, rough
stx2 93 78 15 2, 6, 8, 10, 15, 20, 55, 88, 113, 132, 168, 171, x3, x6, NT, rough
stx1, stx2 15 15 0 8, 15, 113, 117, 171, NT
stx1, eae 2 2 0 59, 119
stx1, hlyA 8 3 5 104, NT
stx2, hlyA 19 17 2 2, 8, 88, 113, 139, x25, NT
stx1, stx2, hlyA 31 23 8 2, 55, 87, 88, 106, 113, 139, 153, NT, rough
stx1, stx2, eae 1 1 0 NT
stx1, eae, hlyA 8 6 2 103, 109, 136, 145, NT
stx2, eae, hlyA 20 20 0 6, 10, 117, 165, NT
stx1, stx2, eae, hlyA 12 10 2 21, 88, 121, 131, 153, 162, 165, NT
Total 361 310 51
a Preevis, preevisceration; Post, postprocessing.
b O serogroups of isolates from each virulence genotype are listed. NT, O antigen nontypeable; rough, autoagglutinable strains. Bold indicates a serogroup previously
associated with human disease.
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Fifteen postprocessing samples produced multiple isolates of
detectable O serogroups. Within each sample, all of the iso-
lates belonged to a single serogroup.
One isolate was of a serotype (O6:H6) that has been previ-
ously associated with ETEC. PCR testing indicated that this
isolate did not harbor genes for either the heat-labile or the
heat-stable toxin that is indicative of ETEC (data not shown).
Several isolates of serogroups commonly associated with
EPEC were screened by PCR for the presence of the EAF
plasmid or the gene coding for bundle-forming pili (bfp), both
of which are usually found in EPEC strains. None of the STEC
strains tested were positive for either marker (data not shown).
DISCUSSION
The data presented here show that 58.3% of the beef car-
casses tested in large processing plants in the United States
carried at least one type of non-O157 STEC prior to eviscer-
ation, but the prevalence was reduced, by using various anti-
microbial intervention strategies, to 8.3% of the carcasses
carrying non-O157 STEC at postprocessing. The samples
surveyed were collected during the summer months, which
have been associated with a peak in the prevalence of bovine
STEC carriage (37). Therefore, STEC carcass contamination
may be much less frequent at other times of the year.
Rogerie et al. reported a lower postprocessing non-O157
STEC prevalence (1.9%) on carcasses sampled during the
summer at processing plants in France (29). Similarly, the
non-O157 STEC prevalence on carcasses processed in Hong
Kong was reported to be 1.7% (18). These apparently lower
prevalence levels could come from a variety of factors but are
most likely due to the use of dissimilar methods of STEC
isolation. The methods used in both of these reports screened
100 or fewer colonies per sample, whereas we screened ap-
proximately 2,000 colonies per sample. In the previous studies,
10.7 and 11.4% of the postprocessing carcass samples were
identified by PCR as carrying Shiga toxin genes, indicating a
prevalence level similar to that described here (8.3% by colony
hybridization, 13.4% by PCR) (18, 29). Neither of the previous
studies reported STEC prevalence on carcasses prior to the
application of antimicrobial interventions.
The hides and feces of animals presented for slaughter have
been shown to be major sources of pathogens in processing
plants (2, 13). To our knowledge, there have been no previous
studies reporting non-O157 STEC prevalence on cattle hides
to date. The prevalence of non-O157 STEC in the feces of beef
cattle in the United States has scarcely been studied. One
report using a small sample of heifers (n  23) found fecal
prevalence to range from 0 to 10% (33). Reported levels of
non-O157 STEC in the feces of dairy cattle in the United
States have ranged from 5.8 to 19.0% (10, 38, 41). There have
been several studies of fecal prevalence of non-O157 STEC in
beef cattle in other countries. Two studies testing healthy cattle
in France recovered non-O157 STEC from 7.9 and 34% of the
samples tested (28, 29). PCR results reported by these groups
indicate that even higher levels of STEC were actually present,
as stx genes were identified in 18 and 70% of the samples tested
(28, 29). Kobayashi et al. detected stx genes, by using a nested
PCR approach, in 100% of the cattle fecal samples obtained at
an abattoir in Japan (17).
It is not clear what proportion of non-O157 STEC bacteria
detected in cattle feces or on beef carcasses is able to cause
disease in humans. Gyles et al. put forward the idea that STEC
virulence is likely to be on a continuum, implying that virtually
all STEC bacteria could be pathogenic under the proper cir-
cumstances (16). This would mean that less virulent strains
could cause the same types of disease as highly virulent strains,
given a sufficiently large dose and a sufficiently low immune
status of the infected individual. Although there are most cer-
tainly nonpathogenic STEC bacteria in the continuum, there
are not enough data to allow a determination of which STEC
bacteria in the food supply represent a potential threat to
human health.
Even though the set of virulence factors necessary to cause
EHEC-related disease has not been defined strictly, associa-
tions between the carriage of certain genes and the ability to
cause severe disease in humans have been made. Toxin-profil-
ing studies of O157:H7 clinical isolates by Ostroff et al. showed
that patients infected with isolates carrying only stx2 were 6.8
times more likely to develop severe disease than those infected
with strains carrying stx1 or both stx1 and stx2 (23). Another
study determined that, within a particular serotype, the car-
riage of stx2 increases an isolate’s likelihood of association with
severe disease fivefold (7). It has also been demonstrated that
Stx2 has a lower 50% lethal dose than does Stx1 when admin-
istered to mice (32). Therefore, isolates carrying stx2 poten-
tially represent an increased threat to human health. Of the
non-O157 STEC isolates recovered in this study, 36.6% carried
TABLE 4. Serogroup distribution of non-O157 STEC isolatesa
Serogroup
No. of isolatesb
Total Preevis Post
O142 54 46 8
O121 31 31 0
O2 22 19 3
O171 18 18 0
O113 15 12 3
O132 14 13 1
O8 13 11 2
O88 10 10 0
O6 9 8 1
O139 9 5 4
O172 9 7 2
OX3 9 3 6
O104 5 1 4
O117 5 5 0
O15 4 4 0
O165 4 4 0
O3 3 3 0
O55 3 3 0
O153 3 3 0
O168 3 0 3
O10 2 2 0
O45 2 2 0
O103 2 2 0
O109 2 0 2
O119 2 2 0
O145 2 2 0
OX25 2 2 0
a Bold indicates a serogroup previously associated with human disease. Sero-
groups with only one isolate: O20, O21, O59, O68, O74, O81, O87, O106, O128,
O131, O136, O162, and OX6. Not listed are 87 Ont and 4 Orough isolates.
b Preevis, preevisceration; Post, postprocessing.
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stx2 either alone or in combination with the accessory virulence
factors intimin and/or EHEC hemolysin.
Several epidemiological studies have associated the posses-
sion of eae by STEC with severe disease (1, 5, 8). In addition,
EHEC hlyA has been found in a high proportion of non-O157
STEC strains causing human disease (12, 16, 30). Therefore,
irrespective of serotype, carriage of the combination of stx, eae,
and EHEC hlyA may be a good indicator of the pathogenic
potential of STEC strains (21). We identified 36 isolates
(11.6%) from 31 preevisceration samples and 4 isolates (7.8%)
from 2 postprocessing samples that carried stx, eae, and EHEC
hlyA.
HUS cases have been reported in which the STEC isolates
did not contain eae (8, 26, 44). It has been assumed that these
isolates used other means of attachment to the intestinal epi-
thelium (25). Without knowing the ingested dose in these cases
and the immunological status of the persons preinfection, the
virulence of such isolates cannot be estimated. We isolated 58
strains, 12 from postprocessing samples, that possessed stx2
and matched the serogroups (O2, O6, O55, O113, O168, and
OX3) of eae-negative strains isolated from HUS patients (8,
26, 44).
Serotype has been reported to be the most consistent factor
for predicting the disease-causing potential of an STEC strain
(16). More than 150 serotypes have been associated with
human disease (www.sciencenet.com.au/vtectable.htm), while
more than 200 serotypes of STEC have been isolated from
cattle (16, 22). Non-O157 serogroups commonly identified in
clinical cases in the United States include O111, O26, O121,
and O103 (1). Surprisingly, no isolates of serogroup O111 or
O26 were recovered from beef carcasses in this study. The
serogroup (O142) that was most common among the isolates
we identified has rarely been associated with STEC (34).
O121 was the most common serogroup we recovered that
has been associated with human disease previously (19, 31).
Only 1 of the 31 O121 isolates carried stx2, eae, and EHEC hlyA
in addition to stx1. Overall, of the 361 isolates described here,
178 (49%) belonged to an O serogroup previously associated
with human disease. Twelve isolates belonged to serogroups
previously associated with human disease (O6, O103, O121,
O145, O153, and O165) and carried eae and EHEC hlyA.
However, none of these 12 isolates were recovered from post-
processing samples.
A comparison of the number of samples that were positive
for stx genes by PCR and the number of samples from which
STEC were isolated indicates that the STEC prevalence levels
presented here underestimate the actual STEC prevalence.
PCR screening showed that 146 (76.8%) of 190 O157-negative
samples possessed Shiga toxin genes; however, isolates were
only recovered from 96 (50.5%) of these samples. Secondly,
PCR results for several samples indicated the presence of both
stx1 and stx2 while the isolates recovered from those samples
contained stx1 or stx2 but not both. These differences are not
surprising, since the sensitivity of PCR is greater than that of
colony hybridization. The PCR method used here has been
shown to detect one STEC cell in a background of 104 cells,
which is at least 10-fold more sensitive than the colony hybrid-
ization method used herein to isolate STEC (24). In addition,
the samples used in this study were from enrichments in se-
lective media that had been frozen for 2 years. Under such
conditions, it is likely that some STEC bacteria would no
longer be viable. The nonviable organisms would contribute to
the number of PCR-positive samples but would not be isolated
by colony hybridization. Therefore, a possibility exists that the
prevalence of non-O157 STEC has been underestimated.
In addition, the variation of serotypes and virulence geno-
types detected would likely have been greater if more isolates
had been characterized. As was seen with some carcasses in
this study, several different serogroups can be present on a
single carcass. Since we only selected, at most, three presump-
tive STEC isolates from each sample, the serogroup and viru-
lence genotype populations were certainly not exhausted for
some carcasses.
In summary, we report here that a non-O157 STEC preva-
lence of greater than 50% exists on beef carcasses prior to
evisceration during processing in U.S. plants. The non-O157
STEC load on carcasses was reduced to 8.3% by in-plant an-
timicrobial interventions. Subsequently, non-O157 STEC bac-
teria possessing accessory virulence factors indicative of patho-
genic strains were identified on only two carcasses (0.6%)
postprocessing.
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